Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 43 out of 100. Health systems and care delivery

Topic: Risk, prevention and care in population studies

Structural brain imaging is guideline-recommended for cases with newly diagnosed cognitive impairment. Adherence to this recommendation and differences by Medicare coverage type are not known. We determined the structural imaging rate overall and by Medicare coverage type: traditional Medicare, Medicare Advantage and dual eligibility for Medicare and Medicaid ("duals") and diagnosis: mild cognitive impairment (MCI) and dementia. In this cross-sectional study, we used the 100% data for traditional Medicare and Medicare Advantage from 2020 through 2022. A total of 1,095,947 community-dwelling Medicare beneficiaries aged 65 to 84 were newly diagnosed with cognitive impairment in 2021; 373,561 (34.1%) with mild cognitive impairment (MCI) and 722,386 (65.9%) with dementia. We determined receipt of structural imaging with MRI or CT scan within 365 days before or after the diagnosis. Overall imaging rates within 365 days of diagnosis were 56.6% overall and 65.9% and 50.5% for an initial diagnosis of dementia and MCI, respectively. Rates were higher for non-dual than dual beneficiaries in traditional Medicare (60.5% vs 57.9%) and members of Medicare Advantage Plans (54.35 vs 52.7%). The initial scan was performed with an MRI in 29.3% of cases with lower rates in duals and Medicare Advantage. In the 2021 full Medicare population with a new diagnosis of cognitive impairment, structural brain imaging was substantially underused. This gap in appropriate care was accentuated in Medicare Advantage Plan members and the socioeconomically disadvantaged dually eligibles. Sustained efforts are needed to ensure equitable adherence to this guideline-recommended procedure.

Key findings

Why it matters

Among about 1.1 million Medicare beneficiaries newly diagnosed with cognitive impairment in 2021, only 56.6% received a recommended structural brain scan (MRI or CT) within a year of diagnosis, with lower rates for dual-eligible beneficiaries and Medicare Advantage members. This describes gaps in diagnosis, not any treatment, cure or prevention of Alzheimer's disease.

Study details

How this study scored 43/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 1 of 4; Study design 4 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 5 of 5; Sample size 4 of 4; Effect reported 2 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record left out, no data; Institution's track record 2 of 3; Multi-centre collaboration 0 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. 41 of the 96 points it could be judged on, which is 43 of 100. Total 43 of 100.41 of the 96 points we could judge = 43 of 100

Published in a peer-reviewed journal, and it is a snapshot of people at one point in time. Scored zero for randomised / blinded because the record does not state it. We have no data on senior author's track record, so that was left out: it earned 41 of the 96 points we could judge it on, which is 43 out of 100.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of the American College of Radiology : JACR)
Journal's citation record 1 / 4 Journal of the American College of Radiology: journal h-index 110 (OpenAlex, 2026-10-29)
Study design 4 / 12 A snapshot of people at one point in time
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 4 / 4 1,095,947 participants
Effect reported 2 / 3 Effect reported as a number, without an interval or test
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record — / 4 OpenAlex's profile for last-listed author Kimberly Altunkaynak holds only 1 work(s), too few to judge a track record — left out of this score
Institution's track record 2 / 3 University of Southern California: institution h-index 1,521 (OpenAlex)
Multi-centre collaboration 0 / 3 OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete)
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 42744196)
Free to read 0 / 2 Behind a paywall — scores zero
Points 41 / 96 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 41 of the 96 points we could judge it on is 43 out of 100.
Total 43 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Soeren, M., Ying, L., Wei, Y., & Kimberly, A. (2026). Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type. Journal of the American College of Radiology : JACR. https://doi.org/10.1016/j.jacr.2026.09.002

Vancouver

Soeren M, Ying L, Wei Y, Kimberly A. Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type. Journal of the American College of Radiology : JACR. 2026. doi:10.1016/j.jacr.2026.09.002. PMID: 42744196.

BibTeX

@article{soeren2026-42744196,
  author  = {Soeren, Mattke and Ying, Liu and Wei, Ye and Kimberly, Altunkaynak},
  title   = {{Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type}},
  journal = {Journal of the American College of Radiology : JACR},
  year    = {2026},
  doi     = {10.1016/j.jacr.2026.09.002},
  pmid    = {42744196},
  url     = {https://doi.org/10.1016/j.jacr.2026.09.002}
}

Related studies in Health systems and care delivery

Also tagged “assessment”

840 studies in the library carry the topic tag “assessment”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.

Similar studies

More on Health systems and care delivery

See all studies in Health systems and care delivery →